Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Bovine, Dog, Human, Mouse, Pig|
|Host / Isotype||Goat / IgG|
|Immunogen||synthetic peptide GEKNGDAKTFWME (Human) (N terminal).|
|Purification||Antigen affinity chromatography|
|Storage buffer||TBS, pH 7.3, with 0.5% BSA|
|Contains||0.02% sodium azide|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||0.3-1 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA1-31091 detects SETDB2 from human samples.
PA1-31091 has been successfully used in Western blot applications.
The PA1-31091 immunogen is: Synthetic peptide: GEKNGDAKTFWME (Human) (N terminal).
Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 (see MIM 601128) methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity (Zhang et al., 2003 [PubMed 12754510]).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
C13orf4; chronic lymphocytic leukemia deletion region gene 8 protein; CLLD8; CLLL8; DKFZp586I0123; DKFZp761J1217; histone-lysine N-methyltransferase SETDB2; KMT1F; lysine N-methyltransferase 1F; Setdb2-Phf11-1-Phf11-2 fusion
BOS_12332; C13orf4; CLLD8; CLLL8; Gm293; KMT1F; SETDB2